🕵️ Cocrystal Pharma, Inc. ($COCP)
SEC insider & ownership activity, last 12 months · CIK 1412486 · every row links its SEC filing
Over the last 12 months insiders bought $220K with no open-market selling against it. Frost Phillip MD ET AL bought $220K (Nov–Feb). Phillip Frost, M.D. added 10.6% → 17.8%; Frost Gamma Investments Trust added 10.1% → 17.4%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $220K (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Frost Phillip MD ET AL | 9 | $220K | 0 | – | Feb 24, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Phillip Frost, M.D. | 17.8% | 13D | Oct 28, 2025 | filing ↗ | |
| Frost Gamma Investments Trust | 17.4% | 13D | Oct 28, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jul 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 2, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 1, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 28, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 28, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 27, 2025 | filing ↗ |